Fendler et al. also prospectively assessed the accuracy of 68Ga-PSMA PET in patients with BCR after RT and/or RP and established high positive predictive value, detection rate, and inter-reader agreement for the localization of recurrent prostate cancer with PSMA PET [20]. This evidence concerns the gene FOLH1 and Familial prostate cancer.